Review
[Biosimilar products--cheaper version of biological drugs. New possibilities within several therapeutic fields]
[Article in
Swedish]
Affiliations
- PMID: 19583014
Item in Clipboard
Review
[Biosimilar products--cheaper version of biological drugs. New possibilities within several therapeutic fields]
[Article in
Swedish]
Lakartidningen.
2009 Jun.
No abstract available
Similar articles
-
Biosimilar epoetins and other "follow-on" biologics: update on the European experiences.Am J Hematol. 2010 Oct;85(10):771-80. doi: 10.1002/ajh.21805. Am J Hematol. 2010. PMID: 20706990 Review.
-
Implementation of the biosimilar pathway: economic and policy issues.Seton Hall Law Rev. 2011;41(2):511-57. Seton Hall Law Rev. 2011. PMID: 21739758 No abstract available.
-
[Biosimilar: can we manage biopharmaceutical heterogeneity?].G Ital Nefrol. 2008 May-Jun;25(3):275. G Ital Nefrol. 2008. PMID: 18473296 Italian. No abstract available.
-
Biosimilars: current status and future directions.Expert Opin Biol Ther. 2010 Jul;10(7):1011-8. doi: 10.1517/14712591003796553. Expert Opin Biol Ther. 2010. PMID: 20384525 Review.
-
[Why is a biosimilar medicinal product not a generic medicinal product?].Rev Prat. 2009 Dec 20;59(10):1340-3. Rev Prat. 2009. PMID: 20058749 French. No abstract available.
Cited by
-
Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?Eur J Health Econ. 2014 Apr;15(3):223-8. doi: 10.1007/s10198-013-0538-4. Epub 2013 Nov 23. Eur J Health Econ. 2014. PMID: 24271016 Free PMC article. Review. No abstract available.